Nova Biomedical recognizes Apheresis Awareness Day 🩸 on Sept 16, 2025. Celebrating the professionals whose expertise saves lives and advances patient care through evidence-based practice. #ApheresisAwareness #AAD2025

As Dermatology Continues to Grow, Pediatric Derm Numbers Lag Pediatric dermatologists love what they do but struggle to attract others to their subspecialty.

Pediatric dermatology continues to struggle to attract clinicians to the subspecialty but those in the field say they love their work. via @medscape.com

#MedSky #DermSky #AAD2025 #pediatrics #PedSky #medicine

@thejidjournal.bsky.social Social Media Editor Chengfeng Zhang, Managing Editor Elizabeth Blalock and Editor-in-Chief Erwin Tschachler attending the #AAD2025 last week
#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #dermatologyresearch

Last weekend, Dr. Nghiem & Peter Ch'en (Research Fellow) took their #AAD adventure to new heights — literally — by riding the Orlando SlingShot, the world’s tallest slingshot ride! 😱💨🎢 #DermDareDevils #AAD2025

Some amazing new data presented at #AAD2025. A new #Tyk2 hits #PASI100 in 50% of patients, #Deucravacitinib offers new hope for patients with #lupus and astounding safety and efficacy of #Icotrokinra for #psoriasis.

Details at: www.healio.com/news/dermato...
#DermSky #RheumSky

🌴🏖 What an incredible honor to be surrounded by so many brilliant minds at #AAD2025! Our faculty & trainees had a fantastic time exploring the latest advancements in #dermatology, sharing their expertise, & connecting w/ peers & industry leaders.

Read our AAD recap 👉 derm.uw.edu/news/uw-derm...

Honoured to present on evidence based care in #psoriasis alongside amazing speakers for alopecia areata, urticaria, CTCL, acne, and photoaging at the #AAD2025 yesterday.

Learnt a lot from all the speakers on the topics at hand as well as how to get complex messages across

I’m wondering if we have enough #dermatology folks on here to make a #DermSky starter pack at #AAD2025. I know I tagged a few folks while welcoming some new accounts, but of course forgot many. If you’re in #derm, pls feel free to reply here, & will try to figure out how to make a starter pack

Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting!
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.

#StandUpForScience
@aadmember.bsky.social

Much needed study on new therapies in bullous pemphigoid - more sustained remission for dupilumab after corticosteroid taper

#AAD2025

Slow and steady response for rocatinlimab, OX40 receptor inhibitor for atopic dermatitis

Looks like it is quite targeted and safe in this phase III study - but if the thought is a slower response they probably needed to have a later primary outcome timepoint

#AAD2025

Nice to see new therapies coming through for cutaneous lupus erythematosus - phase II data on deucravacitinib for CLE

#AAD2025

Icotrokinra showing high but slightly lower response rates compared to injectable IL23i for #psoriasis - nonetheless a very high effectiveness for an oral medication

#AAD2025

Much needed study to look at the impact of dupilumab on itch in epidermolysis bullosa and ichthyosis

need a bigger study with a control arm but very promising!

#AAD2025

ESK-001 showing promise as a targeted inhibitor of TYK2 for psoriasis in a phase II trial - now for the phase III study to confirm findings for blinded primary outcome

#AAD2025

Very high negative predictor values presented by Skin Analytics for their DERM AI device in ruling out melanoma

I think gold standard for this based on dermatologist diagnosis is still suboptimal and would like longer term data with follow up

#AAD2025

Nice early results from a small phase IIa trial on Bempikibart, IL7/TSLP inhibitor biologic for alopecia areata in the late breaking session by Brett King

Looks like it results in more durable responses compared to JAK inhibitors after treatment cessation

#AAD2025

Fascinating use of AI to increase access to patch testing for allergic contact dermatitis from the Mayo Clinic

#AAD2025

Always love the excitement of the #AAD mtg for #dermatology. But as I sit in scientific sessions, I want my clinical/industry colleagues & patient advocacy groups to know #NIH funded research was critical for delivering nearly all modern therapies we use for our patients #AAD2025 #StandUpForScience

Really nice start to the 2025 debates session at #AAD2025 by Eugene Semenov and Sharon Wongvibulsin on the advantages, use cases, and limitations of AI in dermatology.

Still unclear to me where we can reliably deploy AI in dermatology currently but already widely in use

AAFA is at the AAD Annual Meeting in Orlando! We’ve got resources on allergic conditions – like asthma, atopic dermatitis and eczema – and type 2 inflammation.

Learn more about the link between allergic diseases and type 2 inflammation: aafa.org/type2

#AAD2025

I’ll be speaking at #aad2025. Come join me!

Friday: C002 - conquer the boards, core
C006 - conquer the boards, applied
Monday: S053 - consultative dermatology for the hospitalized patient
S066 - advanced therapeutics for complex disease
F099 - skin and systemic malignancy

#dermsky #medsky

GentleCure by SkinCure Oncology logo above an invite to visit booth number 3173 at the American Academy of Dermatology Annual Meeting.

Learn about partnership, treatment innovation, and patient-centered skin cancer care at the American Academy of Dermatology Annual Meeting. #AAD2025

✈️🏖 Thrilled to join #dermatology peers & industry leaders this week at #AAD2025 in Orlando! This year, over 15 of our incredible faculty & trainees are taking the stage to share their research & expertise. Check out the full list here 👉 derm.uw.edu/news/2025-aad-sessions

Excited to attend #AAD2025 in Orlando next week and to lead our session on "Leveraging Teledermatology to Improve Patient Access." Mark your meeting agenda to join us on Sunday at 1:00 PM in Room W314B.

Join me at #AAD2025 S065 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness on Monday 10th March in Valencia Ballroom D

I will be presenting on Evidence based care of #psoriasis alongside great speakers @DrScottElman @DrShasaHu @AMostaghimi

@AADmember

@roxanadaneshjou.bsky.social @drsteventchen.bsky.social @drjohnbarbieri.bsky.social I will know #DermSky has made it when we have an #AAD2025 starter pack and are discussing/posting/actually eating crickets as sustainable food.